Yuko Tanaka

4.8k total citations · 1 hit paper
217 papers, 3.7k citations indexed

About

Yuko Tanaka is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yuko Tanaka has authored 217 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 48 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Yuko Tanaka's work include Glioma Diagnosis and Treatment (16 papers), Epoxy Resin Curing Processes (12 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Yuko Tanaka is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Epoxy Resin Curing Processes (12 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Yuko Tanaka collaborates with scholars based in Japan, France and Germany. Yuko Tanaka's co-authors include Nawal Kishor Mal, Masahiro Fujiwara, Yoichi Nakazato, Masahiko Matsukata, Takahisa Taguchi, Shigeo Tsukahara, Seiichi Okabe, Hiroko Ohgaki, Bo Ou and Benjamin Brokinkel and has published in prestigious journals such as Nature, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Yuko Tanaka

199 papers receiving 3.6k citations

Hit Papers

Photocontrolled reversible release of guest molecules fro... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Tanaka Japan 27 904 779 482 436 436 217 3.7k
G. H. Rao United States 42 674 0.7× 952 1.2× 598 1.2× 190 0.4× 317 0.7× 332 6.7k
Tianmin Cheng China 25 1.0k 1.1× 1.1k 1.4× 717 1.5× 246 0.6× 690 1.6× 76 4.1k
Shunsuke Ohnishi Japan 39 770 0.9× 1.6k 2.1× 539 1.1× 874 2.0× 388 0.9× 124 5.1k
Christopher R. Chitambar United States 36 359 0.4× 1.5k 1.9× 420 0.9× 417 1.0× 201 0.5× 117 4.5k
Yongping Su China 34 909 1.0× 1.9k 2.4× 765 1.6× 518 1.2× 696 1.6× 141 5.4k
Han Kiat Ho Singapore 34 789 0.9× 1.6k 2.0× 689 1.4× 453 1.0× 801 1.8× 104 4.7k
Paul A. Cahill United States 49 765 0.8× 2.1k 2.7× 475 1.0× 158 0.4× 678 1.6× 203 7.2k
Hiroaki Maeda Japan 47 1.2k 1.3× 1.2k 1.6× 999 2.1× 209 0.5× 98 0.2× 211 6.8k
Avnesh S. Thakor United States 31 678 0.8× 1.2k 1.5× 479 1.0× 422 1.0× 851 2.0× 111 4.4k
Franca Castiglione Italy 33 489 0.5× 696 0.9× 248 0.5× 85 0.2× 400 0.9× 197 4.0k

Countries citing papers authored by Yuko Tanaka

Since Specialization
Citations

This map shows the geographic impact of Yuko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Tanaka more than expected).

Fields of papers citing papers by Yuko Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Tanaka. The network helps show where Yuko Tanaka may publish in the future.

Co-authorship network of co-authors of Yuko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Tanaka. A scholar is included among the top collaborators of Yuko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Tanaka. Yuko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naganuma, Atsushi, Nozomi Sano, Tomoyuki Masuda, et al.. (2023). Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab. Internal Medicine. 62(21). 3151–3156. 1 indexed citations
3.
Hamada, Takashi, et al.. (2023). Effect of the Amine Hydrochloride Salt on the Antifogging Properties of Amino-Functionalized Polysilsesquioxane. ACS Applied Polymer Materials. 5(2). 1596–1605. 4 indexed citations
4.
Tanaka, Yuko, et al.. (2023). The Effects of Black Tea Consumption on Intestinal Microflora—A Randomized Single-Blind Parallel-Group, Placebo-Controlled Study. Journal of Nutritional Science and Vitaminology. 69(5). 326–339. 6 indexed citations
5.
Tanaka, Yuko, et al.. (2022). Real-time PCR Method for Detection of Short DNA using a Deoxyuridine Probe and Application for Detection of Fomivirsen. BioTechniques. 73(6). 281–287. 1 indexed citations
6.
Matsumoto, Yoshihisa, Shigeki Umemura, Daisuke Fujisawa, et al.. (2021). Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme. Japanese Journal of Clinical Oncology. 52(4). 375–382. 4 indexed citations
7.
Okabe, Seiichi, Yuko Tanaka, & Akihiko Gotoh. (2021). Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma. Experimental Hematology and Oncology. 10(1). 19–19. 14 indexed citations
8.
Tanaka, Yuko. (2021). Inhibitory Effects on Acute Upper Respiratory Tract Inflammation with Black Tea Consumption―A Randomized Single—blind Parallel—group, Placebo—controlled Study―. 49(2). 273–288. 1 indexed citations
9.
Okabe, Seiichi, et al.. (2020). Effect of dual inhibition of histone deacetylase and phosphatidylinositol-3 kinase in Philadelphia chromosome-positive leukemia cells. Cancer Chemotherapy and Pharmacology. 85(2). 401–412. 8 indexed citations
10.
Tanaka, Yuko, Tetsuya Okano, Yujin Kudo, et al.. (2019). EP1.04-26 Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S979–S980. 2 indexed citations
11.
Okabe, Seiichi, Yuko Tanaka, Tetsuzo Tauchi, & Kazuma Ohyashiki. (2018). Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation. Annals of Hematology. 98(3). 723–733. 15 indexed citations
12.
Okabe, Seiichi, Tetsuzo Tauchi, Yuko Tanaka, & Kazuma Ohyashiki. (2017). Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Philadelphia Chromosome-Positive Leukemia Cells. Blood. 130. 5241–5241. 1 indexed citations
13.
Yamashita, Yuji, Yuko Tanaka, Seishi Kono, et al.. (2017). Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report. Breast Care. 12(1). 43–45. 4 indexed citations
15.
Kim, Young Ho, Sumihito Nobusawa, Michel Mittelbronn, et al.. (2010). Molecular Classification of Low-Grade Diffuse Gliomas. American Journal Of Pathology. 177(6). 2708–2714. 175 indexed citations
16.
Kitagawa, Shuji, et al.. (2009). Enhanced skin delivery of quercetin by microemulsion. Journal of Pharmacy and Pharmacology. 61(7). 855–860. 16 indexed citations
17.
Kitagawa, Shuji, et al.. (2009). Enhanced skin delivery of quercetin by microemulsion. Journal of Pharmacy and Pharmacology. 61(7). 855–860. 44 indexed citations
18.
Fujimoto, Kiminori, Keisuke Tanaka, Junya Yamamoto, et al.. (2009). Volume of pulmonary lobes and segments in chronic obstructive pulmonary diseases calculated using newly developed three-dimensional software. Japanese Journal of Radiology. 27(3). 115–122. 9 indexed citations
19.
Miyata, Hideaki, et al.. (1998). An Investigation on the Actual Conditions During the Initial visit of Patients at the Pedodontic clinic of Niigata University Dental Hospital : in comparison with 1980, 1988 and 1996. 36(4). 652–659. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026